These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6218118)

  • 1. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
    Dzierzanowska D; Patzer J; Jeljaszewicz J
    Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies with azlocillin, mezlocillin, penicillin-g-potassium and sisomicin on tolerance in the cornea and the kinetics of inhibiting concentrations in the cornea and aqueous humor in rabbits].
    Gauri KK; Finck J; Claussen B; Schassan HH; Fedder J; Weuta H
    Infection; 1982; 10 Suppl 3():S221-6. PubMed ID: 6218119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transperitoneal resorption of oxacillin, azlocillin and sisomicin in continuous ambulatory peritoneal dialysis in patients with and without peritonitis].
    Thomae U; Boos W; Adam D
    Med Welt; 1981 Sep; 32(37):1365-7. PubMed ID: 7300642
    [No Abstract]   [Full Text] [Related]  

  • 6. The combined action of azlocillin and sisomicin in a model simulating the in vivo serum kinetics.
    Haller I
    Infection; 1983; 11 Suppl 2():S81-2. PubMed ID: 6423547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal function.
    Kampf D; Schurig R; Bergs A; Förster D
    Clin Nephrol; 1983 Jan; 19(1):37-44. PubMed ID: 6219847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
    Lode H; Niestrath U; Koeppe P; Langmaack H
    Infection; 1977; 5(3):163-9. PubMed ID: 334673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.
    Haller I
    Infection; 1982; 10 Suppl 3():S229-33. PubMed ID: 6818155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U; Weber E
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
    J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro effect of acylureido penicillins and mezlocillin on anaerobic sporeless gram-negative rods of genus Bacteroides].
    Höhne C
    Infection; 1982; 10 Suppl 3():S238-43. PubMed ID: 6218120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decrease of sisomicin nephrotoxicity as affected by cephalothin: pharmacokinetic evaluation].
    Gagaeva EV; Firsov AA; Egorenko GG; Berezina EK; Shtegel'man LA
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):190-6. PubMed ID: 4015061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin.
    Lode H; Kemmerich B; Koeppe P
    Antimicrob Agents Chemother; 1975 Oct; 8(4):396-401. PubMed ID: 1103722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of sisomicin in humans.
    Chung M; Schrogie JJ; Symchowicz S
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):535-51. PubMed ID: 7334458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of azlocillin and mezlocillin by the normal pancreas and in acute pancreatitis in dogs and rats.
    Demol P; Singer MV; Bernemann D; Linzenmeier G; Goebell H
    Digestion; 1983; 27(2):93-9. PubMed ID: 6628842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.